LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Article ; Online: The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder.

    Mahoney, James J / Kalechstein, Ari D / Newton, Thomas F / De La Garza, Richard

    Journal of psychopharmacology (Oxford, England)

    2017  Volume 31, Issue 8, Page(s) 989–995

    Abstract: It is well-documented in the literature that cocaine use is associated with neurocognitive impairment. The manner in which patterns of cocaine use, such as years of use, recent use over the past month, and daily amount of cocaine use, moderate ... ...

    Abstract It is well-documented in the literature that cocaine use is associated with neurocognitive impairment. The manner in which patterns of cocaine use, such as years of use, recent use over the past month, and daily amount of cocaine use, moderate neurocognition has been studied in a relatively piecemeal manner. Hence, the purpose of the study was to evaluate whether cocaine use patterns modulate neurocognition in individuals with cocaine use disorder. Cocaine users who were cocaine-negative ( n=125) were divided into tertiles based on cocaine use patterns and the performances of the highest and lowest groups were compared on the following cognitive measures: Continuous Performance Task-II, n-back, and Hopkins Verbal Learning Task-Revised. Participants with cocaine use disorder who used for more years (25.2±0.6 versus 10.1±0.6 years; mean±standard error of the mean) and who had more recent cocaine use over the past month (26.3±0.5 versus 6.0±0.6 days) did not differ significantly on any of the neurocognitive variables when compared to those with use patterns of shorter duration and less frequency (all p's >0.05). Lastly, participants reporting the greatest amount daily cocaine use (1.8±0.0 g) demonstrated better performance on an auditory working memory task when compared to those with the lowest daily use (0.7±0.0 g; p=0.04). While one might expect that individuals who used greater amounts of cocaine over longer periods of time would demonstrate relatively poorer performance on measures of neurocognition, particularly in the initial phase of abstinence, our findings did not confirm this. While speculative, a potential explanation for these findings is that after an individual uses cocaine for a certain number of years, or uses a specific amount over time, then the deleterious effects of cocaine on neurocognition stabilizes, and increased duration of cocaine use does not further exacerbate those impairments.
    MeSH term(s) Adolescent ; Adult ; Cocaine-Related Disorders/complications ; Cocaine-Related Disorders/psychology ; Cognition Disorders/chemically induced ; Cognition Disorders/complications ; Cognition Disorders/psychology ; Female ; Humans ; Male ; Middle Aged ; Neuropsychological Tests ; Retrospective Studies ; Risk Factors ; Time Factors ; Young Adult
    Language English
    Publishing date 2017-07-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 639313-5
    ISSN 1461-7285 ; 0269-8811
    ISSN (online) 1461-7285
    ISSN 0269-8811
    DOI 10.1177/0269881117715606
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders.

    Mahoney, James J / Kalechstein, Ari D / De Marco, Anthony P / Newton, Thomas F / De La Garza, Richard

    Neuropsychology

    2017  Volume 31, Issue 3, Page(s) 311–318

    Abstract: ... Cohen's d]), the magnitude of group differences was greatest between the average and below average groups ...

    Abstract Objective: To determine whether premorbid IQ mediates performance on neurocognitive tests in individuals diagnosed with cocaine use disorder (CUD).
    Method: Recently abstinent cocaine users (N = 113) completed measures sensitive to the effects of cocaine on cognition: Conners' Continuous Performance Task-II (CPT-II), n-back working memory test, and Hopkins Verbal Learning Task-Revised (HVLT-R). Premorbid IQ was calculated using the Oklahoma Premorbid Intelligence Estimate, which integrates scores from the Wechsler Adult Intelligence Scale-III and demographic variables. Participants were grouped according to their premorbid IQ using commonly accepted classifications of ability level (above average [>110], average [90-109], and below average [<90]) and comparisons in neurocognitive performance were performed using one-way analysis of variance.
    Results: Significant differences were detected between groups on the HVLT-R including Trial 1 (p = .002), total word recall across the 3 list-learning trials (p < .001), and recall following a delay (p < .001). Significant differences were also detected on the N-back, including auditory and visual accuracy (p = .022 and p < .001, respectively) and mean and maximum block length (p < .001). Although significant differences were observed between the above average and average groups (mean effect size = .418 [Cohen's d]), the magnitude of group differences was greatest between the average and below average groups (mean effect size = .716).
    Conclusions: These results raise questions as to whether the neurocognitive impairment observed in individuals diagnosed with CUD predated the onset of cocaine use or whether the impairments were caused by cocaine use. Because these impairments are potential risk factors for poor treatment outcomes, it is important to consider the need to modify treatment programs to account for lower premorbid IQ. (PsycINFO Database Record
    MeSH term(s) Adult ; Cocaine/adverse effects ; Cocaine-Related Disorders/complications ; Cocaine-Related Disorders/psychology ; Cognition ; Cognition Disorders/diagnosis ; Cognition Disorders/etiology ; Female ; Humans ; Intelligence ; Male ; Memory, Short-Term ; Mental Recall ; Middle Aged ; Neuropsychological Tests ; Verbal Learning ; Wechsler Scales
    Chemical Substances Cocaine (I5Y540LHVR)
    Language English
    Publishing date 2017-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1042412-x
    ISSN 1931-1559 ; 0894-4105
    ISSN (online) 1931-1559
    ISSN 0894-4105
    DOI 10.1037/neu0000344
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.

    Kalechstein, Ari D / Mahoney, James J / Verrico, Christopher D / De La Garza, Richard

    Neuropharmacology

    2014  Volume 85, Page(s) 493–498

    Abstract: Unlabelled: Long-term, high-dose methamphetamine (METH) use is associated with decrements in neurocognition and, given the association between impaired neurocognition and poorer treatment outcomes in individuals dependent on alcohol and drugs, it is ... ...

    Abstract Unlabelled: Long-term, high-dose methamphetamine (METH) use is associated with decrements in neurocognition and, given the association between impaired neurocognition and poorer treatment outcomes in individuals dependent on alcohol and drugs, it is considered to be a neglected area of critical concern. The objective of this study was to determine whether varenicline, a partial agonist at α4β2- and a full agonist at α7-nicotinic acetylcholine receptors, enhances attention/information processing speed, episodic memory, and working memory in non-treatment seeking METH-dependent participants. Twenty-six participants were randomly assigned to receive oral placebo or oral varenicline (titrated up to 1 mg) over 5 days during three separate inpatient phases, and 17 completed each inpatient phase. Participants were predominately male (71%) and Caucasian (71%). Varenicline significantly improved reaction time on the n-back for visual stimuli (F(1,47)=5.369, p=0.025, η2=0.103), and a trend was observed for improvement in reaction time for auditory stimuli (F(1,47)=3.141, p=0.083, η2=0.063). For those study participants whose reaction time was in the lower half of the distribution at baseline, the effect was even more pronounced for auditory (F(1,22)=5.287, p=0.031, η2=0.194) and visual (F(1,22)=11.981, p=0.002, η2=0.353) stimuli relative to placebo. In contrast, varenicline did not modulate mean or maximum span of working memory or performance on tests of episodic memory or attention (p's>0.05). Given the potential importance of this finding, it should be replicated in a larger sample over a longer treatment period with a higher dose of varenicline (2 mg).
    Trial registration: clinicalTrials.gov Identifier NCT01571167.
    MeSH term(s) Acoustic Stimulation ; Adult ; Amphetamine-Related Disorders/drug therapy ; Amphetamine-Related Disorders/psychology ; Auditory Perception/drug effects ; Benzazepines/administration & dosage ; Female ; Humans ; Male ; Methamphetamine ; Neuropsychological Tests ; Nicotinic Agonists/administration & dosage ; Nootropic Agents/administration & dosage ; Photic Stimulation ; Quinoxalines/administration & dosage ; Reaction Time/drug effects ; Time Factors ; Treatment Outcome ; Varenicline ; Visual Perception/drug effects
    Chemical Substances Benzazepines ; Nicotinic Agonists ; Nootropic Agents ; Quinoxalines ; Methamphetamine (44RAL3456C) ; Varenicline (W6HS99O8ZO)
    Language English
    Publishing date 2014-06-12
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 218272-5
    ISSN 1873-7064 ; 0028-3908
    ISSN (online) 1873-7064
    ISSN 0028-3908
    DOI 10.1016/j.neuropharm.2014.05.045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Stimulant-associated cognitive abnormalities: mechanisms and impact on reward-related behavior and addiction.

    Kalechstein, Ari D / Jentsch, J David / Kantak, Kathleen M

    Drug and alcohol dependence

    2008  Volume 97, Issue 3, Page(s) 276–280

    MeSH term(s) Behavior, Addictive/epidemiology ; Behavior, Addictive/psychology ; Central Nervous System Stimulants/adverse effects ; Cognition Disorders/chemically induced ; Cognition Disorders/diagnosis ; Cognition Disorders/epidemiology ; Humans ; Neuropsychological Tests ; Reward ; Severity of Illness Index
    Chemical Substances Central Nervous System Stimulants
    Language English
    Publishing date 2008-09-10
    Publishing country Ireland
    Document type News
    ZDB-ID 519918-9
    ISSN 1879-0046 ; 0376-8716
    ISSN (online) 1879-0046
    ISSN 0376-8716
    DOI 10.1016/j.drugalcdep.2008.05.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment.

    Kalechstein, Ari D / De La Garza, Richard / Newton, Thomas F

    The American journal on addictions

    2010  Volume 19, Issue 4, Page(s) 340–344

    Abstract: Modafinil improves working memory in healthy subjects and individuals diagnosed with schizophrenia and Attention Deficit/Hyperactivity Disorder, though the effects of modafinil have not been evaluated on working memory in methamphetamine-dependent ... ...

    Abstract Modafinil improves working memory in healthy subjects and individuals diagnosed with schizophrenia and Attention Deficit/Hyperactivity Disorder, though the effects of modafinil have not been evaluated on working memory in methamphetamine-dependent subjects. This double-blind, placebo-controlled study evaluated whether a daily dose of 400 mg of modafinil, administered over three consecutive days, would enhance performance on a measure of working memory relative to test performance at baseline and following 3 days of placebo administration in 11 methamphetamine addicted, nontreatment-seeking volunteers. The results revealed that participants demonstrating relatively poor performance on the third day of a 3-day washout period (ie, at baseline), showed significant improvement on measures of working memory, but not on measures of episodic memory or information processing speed. In contrast, for participants demonstrating relatively high performance at baseline, modafinil administration did not affect test scores. The findings provide an initial indication that modafinil can reverse methamphetamine-associated impairments in working memory.
    MeSH term(s) Adolescent ; Adult ; Amphetamine-Related Disorders/drug therapy ; Amphetamine-Related Disorders/psychology ; Benzhydryl Compounds/therapeutic use ; Central Nervous System Stimulants/therapeutic use ; Female ; Humans ; Memory, Short-Term/drug effects ; Mental Recall/drug effects ; Middle Aged ; Modafinil ; Neuropsychological Tests
    Chemical Substances Benzhydryl Compounds ; Central Nervous System Stimulants ; Modafinil (R3UK8X3U3D)
    Language English
    Publishing date 2010-12-06
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural
    ZDB-ID 1141440-6
    ISSN 1521-0391 ; 1055-0496
    ISSN (online) 1521-0391
    ISSN 1055-0496
    DOI 10.1111/j.1521-0391.2010.00052.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers.

    Tziortzis, Desey / Mahoney, James J / Kalechstein, Ari D / Newton, Thomas F / De La Garza, Richard

    Pharmacology, biochemistry, and behavior

    2011  Volume 98, Issue 2, Page(s) 196–202

    Abstract: Impulsivity and craving have been independently hypothesized to contribute to sustained drug use and relapse in addiction. The primary focus of this project was to determine the relationship between impulsivity and craving in 85 cocaine-dependent and 73 ... ...

    Abstract Impulsivity and craving have been independently hypothesized to contribute to sustained drug use and relapse in addiction. The primary focus of this project was to determine the relationship between impulsivity and craving in 85 cocaine-dependent and 73 methamphetamine-dependent, non-treatment-seeking volunteers. Drug use was assessed with a 14-item, self-report drug and alcohol use questionnaire. Self report instruments utilized included the Barratt Impulsivity Scale (BIS) and the Visual Analog Scale (VAS), which probed "just before your last use of cocaine (for cocaine-dependent participants) or methamphetamine (for methamphetamine-dependent participants), how much craving did you experience?" The groups were similar with respect to recent use of cocaine or methamphetamine, alcohol, nicotine, and marijuana. Analysis of variance (ANOVA) did not reveal significant differences between cocaine and methamphetamine groups for total impulsivity or total craving. Simple linear regression revealed correlations between total impulsivity and total craving in cocaine (r(2)=0.05, p≤0.03) and methamphetamine users (r(2)=0.09, p≤0.008). Participants were separated into high impulsivity (HIBIS) or low impulsivity (LOBIS) subgroups using a median split. ANOVA revealed significantly higher craving in the HIBIS group versus the LOBIS group in methamphetamine users (p≤0.02), but not in cocaine users. For both cocaine and methamphetamine groups, level of impulsivity and craving were found to be related to some drug use variables including years of alcohol use, severity of withdrawal, and craving level following drug use. Taken together, this study shows a marginal relationship between impulsivity and craving, which may further the understanding of motivational factors contributing to ongoing drug use and addiction in psychostimulant users.
    MeSH term(s) Adolescent ; Adult ; Amphetamine-Related Disorders/psychology ; Behavior, Addictive/psychology ; Cocaine-Related Disorders/psychology ; Female ; Humans ; Impulsive Behavior/psychology ; Male ; Methamphetamine ; Middle Aged ; Surveys and Questionnaires ; Young Adult
    Chemical Substances Methamphetamine (44RAL3456C)
    Language English
    Publishing date 2011-04
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 191042-5
    ISSN 1873-5177 ; 0091-3057
    ISSN (online) 1873-5177
    ISSN 0091-3057
    DOI 10.1016/j.pbb.2010.12.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.

    Mahoney, James J / Kalechstein, Ari D / Verrico, Christopher D / Arnoudse, Nicholas M / Shapiro, Benjamin A / De La Garza, Richard

    Progress in neuro-psychopharmacology & biological psychiatry

    2013  Volume 50, Page(s) 137–142

    Abstract: Long-term cocaine use is a risk factor for the onset of neurocognitive impairment. This study sought to determine whether the cholinesterase inhibitor rivastigmine could improve neurocognitive performance in cocaine-dependent individuals. Cocaine- ... ...

    Abstract Long-term cocaine use is a risk factor for the onset of neurocognitive impairment. This study sought to determine whether the cholinesterase inhibitor rivastigmine could improve neurocognitive performance in cocaine-dependent individuals. Cocaine-dependent individuals who were not seeking treatment at the time of enrollment in the study were randomly assigned to receive placebo (n=16), rivastigmine 3mg (n=13), or rivastigmine 6mg (n=12). The baseline neurocognitive assessment, which included measures of attention/information processing (as measured by the Continuous Performance Task-II (CPT-II)), verbal learning/episodic memory (as measured by the Hopkins Verbal Learning Test-Revised (HVLT-R)), and working memory (as measured by the Dual N-Back Task), was conducted prior to the administration of study medication (Day 0). The follow-up assessment was conducted on Day 8 after the participants had received rivastigmine or placebo for 7days (Day 2-8). Rivastigmine administration significantly improved performance on one measure of working memory span (mean n-back span). This study provides additional data showing that cocaine-associated neurocognitive impairment, specifically working memory deficits, can be remediated, at least to some degree.
    MeSH term(s) Adolescent ; Adult ; Cholinesterase Inhibitors/pharmacology ; Cholinesterase Inhibitors/therapeutic use ; Cocaine-Related Disorders/complications ; Cocaine-Related Disorders/drug therapy ; Cocaine-Related Disorders/psychology ; Cognition Disorders/complications ; Cognition Disorders/drug therapy ; Cognition Disorders/psychology ; Diagnosis, Dual (Psychiatry) ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drugs, Investigational/pharmacology ; Drugs, Investigational/therapeutic use ; Female ; Humans ; Male ; Memory, Short-Term/drug effects ; Middle Aged ; Neuropsychological Tests ; Phenylcarbamates/pharmacology ; Phenylcarbamates/therapeutic use ; Rivastigmine ; Young Adult
    Chemical Substances Cholinesterase Inhibitors ; Drugs, Investigational ; Phenylcarbamates ; Rivastigmine (PKI06M3IW0)
    Language English
    Publishing date 2013-11-12
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural
    ZDB-ID 781181-0
    ISSN 1878-4216 ; 0278-5846
    ISSN (online) 1878-4216
    ISSN 0278-5846
    DOI 10.1016/j.pnpbp.2013.11.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.

    Mahoney, James J / Jackson, Brian J / Kalechstein, Ari D / De La Garza, Richard / Newton, Thomas F

    Progress in neuro-psychopharmacology & biological psychiatry

    2010  Volume 35, Issue 2, Page(s) 459–465

    Abstract: Abstinent methamphetamine (Meth) dependent individuals demonstrate poorer performance on tests sensitive to attention/information processing speed, learning and memory, and working memory when compared to non-Meth dependent individuals. The poorer ... ...

    Abstract Abstinent methamphetamine (Meth) dependent individuals demonstrate poorer performance on tests sensitive to attention/information processing speed, learning and memory, and working memory when compared to non-Meth dependent individuals. The poorer performance on these tests may contribute to the morbidity associated with Meth-dependence. In light of this, we sought to determine the effects of acute, low-dose Meth administration on attention, working memory, and verbal learning and memory in 19 non-treatment seeking, Meth-dependent individuals. Participants were predominantly male (89%), Caucasian (63%), and cigarette smokers (63%). Following a four day, drug-free washout period, participants were given a single-blind intravenous infusion of saline, followed the next day by 30 mg of Meth. A battery of neurocognitive tasks was administered before and after each infusion, and performance on measures of accuracy and reaction time were compared between conditions. While acute Meth exposure did not affect test performance for the entire sample, participants who demonstrated relatively poor performance on these tests at baseline, identified using a median split on each test, showed significant improvement on measures of attention/information processing speed and working memory when administered Meth. Improved performance was seen on the following measures of working memory: choice reaction time task (p≤0.04), a 1-back task (p≤0.01), and a 2-back task (p≤0.04). In addition, those participants demonstrating high neurocognitive performance at baseline experienced similar or decreased performance following Meth exposure. These findings suggest that acute administration of Meth may temporarily improve Meth-associated neurocognitive performance in those individuals experiencing lower cognitive performance at baseline. As a result, stimulants may serve as a successful treatment for improving cognitive functioning in those Meth-dependent individuals experiencing neurocognitive impairment.
    MeSH term(s) Adult ; Amphetamine-Related Disorders/drug therapy ; Amphetamine-Related Disorders/psychology ; Attention/drug effects ; Central Nervous System Stimulants/administration & dosage ; Cognition/drug effects ; Cognition Disorders/drug therapy ; Female ; Humans ; Injections, Intraventricular ; Learning/drug effects ; Male ; Memory/drug effects ; Memory, Short-Term/drug effects ; Methamphetamine/administration & dosage ; Neuropsychological Tests ; Reaction Time/drug effects ; Time Factors ; Verbal Learning/drug effects ; Young Adult
    Chemical Substances Central Nervous System Stimulants ; Methamphetamine (44RAL3456C)
    Language English
    Publishing date 2010-11-29
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 781181-0
    ISSN 1878-4216 ; 0278-5846
    ISSN (online) 1878-4216
    ISSN 0278-5846
    DOI 10.1016/j.pnpbp.2010.11.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.

    Mahoney, James J / Hawkins, Rollin Y / De La Garza, Richard / Kalechstein, Ari D / Newton, Thomas F

    Gender medicine

    2010  Volume 7, Issue 5, Page(s) 414–421

    Abstract: Background: It has been well documented that cocaine and methamphetamine use can lead to the onset of psychotic symptoms similar to schizophrenia. However, the research and literature on gender differences and stimulant-induced psychosis have been mixed. ...

    Abstract Background: It has been well documented that cocaine and methamphetamine use can lead to the onset of psychotic symptoms similar to schizophrenia. However, the research and literature on gender differences and stimulant-induced psychosis have been mixed.
    Objective: The primary aim of this study was to investigate gender differences in the reporting of psychotic symptoms in cocaine- versus methamphetamine-dependent individuals.
    Methods: Participants were recruited from the Los Angeles, California, community via radio and newspaper advertisements. All met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for cocaine or methamphetamine dependence, and all reported either methamphetamine or cocaine as their primary drug of abuse. During a screening interview, participants answered questions from the Psychotic Symptom Assessment Scale, which characterizes various types of psychotic symptoms during drug use ("while high") or during periods of nonuse ("while abstinent").
    Results: Participants included 42 cocaine-dependent individuals (27 men, 15 women) and 43 methamphetamine-dependent individuals (25 men, 18 women). Among cocaine users, there were no significant differences between men and women with regard to ethnicity, years of use, route of administration, and amount used in the past week, though they differed significantly with regard to age (P = 0.029). In the "while abstinent" condition, women were significantly more likely than men to report experiencing auditory hallucinations (13% vs 0%, respectively; P = 0.050) and tactile hallucinations (20% vs 0%; P = 0.016), whereas men were more likely to report delusions of grandeur (48% vs 6%; P = 0.006). During the "while high" condition, women were significantly more likely than men to report delusions of grandeur (13% vs 0%, respectively; P = 0.050), tactile hallucinations (33% vs 0%; P = 0.001), and olfactory hallucinations (13% vs 0%; P = 0.050). Among methamphetamine users, there were no significant differences between men and women with regard to age, ethnicity, years of use, route of administration, or amount used in the past week. In the "while abstinent" condition, women were significantly more likely than men to report feeling that something was wrong with the way a part of their body looked (72% vs 32%, respectively; P = 0.009), olfactory hallucinations (39% vs 8%; P = 0.010) and dressing inappropriately (22% vs 0%; P = 0.010). During the "while high" condition, women were more likely than men to report delusions of grandeur (33% vs 16%, respectively; P = 0.030), paranoia (50% vs 16%; P = 0.017), and tactile hallucinations (61% vs 32%; P = 0.050).
    Conclusions: The findings of the present study revealed that cocaine- and methamphetamine-dependent women were more likely than their male counterparts to report experiencing various psychotic symptoms. This information may be useful for clinicians and mental health professionals, who should take these symptoms into account as potential barriers that may impede effective treatment.
    MeSH term(s) Adult ; Amphetamine-Related Disorders/psychology ; Body Dysmorphic Disorders/epidemiology ; Body Dysmorphic Disorders/etiology ; Chi-Square Distribution ; Cocaine-Related Disorders/psychology ; Delusions/epidemiology ; Delusions/etiology ; Female ; Hallucinations/epidemiology ; Hallucinations/etiology ; Humans ; Linear Models ; Male ; Methamphetamine/adverse effects ; Middle Aged ; Paranoid Disorders/epidemiology ; Paranoid Disorders/etiology ; Prevalence ; Psychoses, Substance-Induced/epidemiology ; Sex Factors ; Surveys and Questionnaires
    Chemical Substances Methamphetamine (44RAL3456C)
    Language English
    Publishing date 2010-11-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2171408-3
    ISSN 1878-7398 ; 1550-8579
    ISSN (online) 1878-7398
    ISSN 1550-8579
    DOI 10.1016/j.genm.2010.09.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.

    Kalechstein, Ari D / Newton, Thomas F / Green, Michael

    The Journal of neuropsychiatry and clinical neurosciences

    2003  Volume 15, Issue 2, Page(s) 215–220

    Abstract: This study documented the association between neurocognitive impairment and methamphetamine dependence in a sample of 27 methamphetamine-dependent individuals who achieved 5 to 14 days of continuously monitored abstinence and in 18 control subjects. ... ...

    Abstract This study documented the association between neurocognitive impairment and methamphetamine dependence in a sample of 27 methamphetamine-dependent individuals who achieved 5 to 14 days of continuously monitored abstinence and in 18 control subjects. Methamphetamine-dependent individuals performed significantly worse than control subjects on neurocognitive measures sensitive to attention/psychomotor speed, on measures of verbal learning and memory, and on executive systems measures sensitive to fluency. These findings are the first to demonstrate that methamphetamine dependence is associated with impairments across a range of neurocognitive domains in a sample of users whose abstinence was continuously monitored with the use of urine screening.
    MeSH term(s) Adult ; Amphetamine-Related Disorders/complications ; Amphetamine-Related Disorders/physiopathology ; Attention/physiology ; Case-Control Studies ; Central Nervous System Stimulants/adverse effects ; Cognition Disorders/complications ; Cognition Disorders/physiopathology ; Female ; Humans ; Inhibition (Psychology) ; Learning/physiology ; Male ; Memory, Short-Term/physiology ; Methamphetamine/adverse effects ; Neuropsychological Tests ; Psychiatric Status Rating Scales ; Psychomotor Performance/physiology ; Verbal Behavior/physiology ; Visual Perception/physiology
    Chemical Substances Central Nervous System Stimulants ; Methamphetamine (44RAL3456C)
    Language English
    Publishing date 2003
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 1036340-3
    ISSN 1545-7222 ; 0895-0172
    ISSN (online) 1545-7222
    ISSN 0895-0172
    DOI 10.1176/jnp.15.2.215
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top